Whitehawk Therapeutics (WHWK) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.26% |
| Dec 31, 2025 | 53.18% |
| Sep 30, 2025 | 28.02% |
| Jun 30, 2025 | 26.43% |
| Mar 31, 2025 | 45.76% |
| Dec 31, 2024 | -5.74% |
| Sep 30, 2024 | -6.78% |
| Jun 30, 2024 | -3.10% |
| Mar 31, 2024 | 0.13% |
| Dec 31, 2023 | 0.09% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.18% |
| Mar 31, 2023 | 19.86% |
| Dec 31, 2022 | 14.00% |
| Sep 30, 2022 | 40.27% |
| Jun 30, 2022 | 32.71% |
| Mar 31, 2022 | 29.87% |
| Dec 31, 2021 | 147.33% |
| Sep 30, 2021 | 161.95% |
| Jun 30, 2021 | 87.17% |
| Mar 31, 2021 | 101.97% |
| Dec 31, 2020 | -2.84% |
| Sep 30, 2020 | 496.33% |
| Jun 30, 2020 | 436.49% |
| Mar 31, 2020 | 330.88% |
| Dec 31, 2019 | 492.79% |
| Sep 30, 2019 | 375.40% |
| Jun 30, 2019 | 537.66% |
| Mar 31, 2019 | 518.91% |
| Dec 31, 2018 | 530.52% |
| Sep 30, 2018 | 482.11% |
| Jun 30, 2018 | 660.38% |
| Mar 31, 2018 | 451.17% |
| Dec 31, 2017 | 435.38% |
| Sep 30, 2017 | 440.33% |
| Jun 30, 2017 | 399.14% |
| Mar 31, 2017 | 331.11% |
| Dec 31, 2016 | 229.81% |
| Sep 30, 2016 | 192.32% |
| Jun 30, 2016 | 180.50% |
| Mar 31, 2016 | 116.09% |
| Dec 31, 2015 | 185.97% |
| Sep 30, 2015 | 22.71% |